AGP Picks
View all

Mining Press Releases
Provided by AGP

Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on July 27, 2026

Dmitry Shubov Consulting Issues Strategic Analysis on Capital-Efficient Delaware Flip Models for Southeast Asian Scale-Ups
Jul. 27, 2026

Dmitry Shubov Consulting Issues Strategic Analysis on Capital-Efficient Delaware Flip Models for Southeast Asian Scale-Ups

Indeterminate GlobeNewswire
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Jul. 27, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Indeterminate GlobeNewswire
Troilus Selected by the Government of Quebec to Receive Specialized Support Through the New Filon Initiative for Strategic Mining Projects
Jul. 27, 2026

Troilus Selected by the Government of Quebec to Receive Specialized Support Through the New Filon Initiative for Strategic Mining Projects

Indeterminate GlobeNewswire
TROILUS SÉLECTIONNÉE PAR LE GOUVERNEMENT DU QUÉBEC POUR BÉNÉFICIER DE L’ACCOMPAGNEMENT SPÉCIALISÉ FILON EN APPUI À L'AVANCEMENT DES PROJETS MINIERS STRATÉGIQUES
Jul. 27, 2026

TROILUS SÉLECTIONNÉE PAR LE GOUVERNEMENT DU QUÉBEC POUR BÉNÉFICIER DE L’ACCOMPAGNEMENT SPÉCIALISÉ FILON EN APPUI À L'AVANCEMENT DES PROJETS MINIERS STRATÉGIQUES

Indeterminate GlobeNewswire
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
Jul. 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

Indeterminate GlobeNewswire
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
Jul. 27, 2026

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Indeterminate GlobeNewswire
Belo Sun Announces Final Resolution of Civil Public Action
Jul. 27, 2026

Belo Sun Announces Final Resolution of Civil Public Action

Indeterminate GlobeNewswire
REPEAT - Helium Evolution Announces $25 Million Financing Anchored by Leading International Investors
Jul. 27, 2026

REPEAT - Helium Evolution Announces $25 Million Financing Anchored by Leading International Investors

Indeterminate GlobeNewswire
Expand Energy Corporation to Acquire Twin Eagle, Creating North America’s Leading Integrated Natural Gas Company
Jul. 27, 2026

Expand Energy Corporation to Acquire Twin Eagle, Creating North America’s Leading Integrated Natural Gas Company

Indeterminate GlobeNewswire
XPO Appoints Michael Kneeland to Board of Directors
Jul. 27, 2026

XPO Appoints Michael Kneeland to Board of Directors

Indeterminate GlobeNewswire
Cielo Announces Executive Changes and Stock Option Grants
Jul. 27, 2026

Cielo Announces Executive Changes and Stock Option Grants

Indeterminate GlobeNewswire
Luckin Coffee to Announce Second Quarter 2026 Financial Results on August 3, 2026
Jul. 27, 2026

Luckin Coffee to Announce Second Quarter 2026 Financial Results on August 3, 2026

Indeterminate GlobeNewswire
Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations
Jul. 27, 2026

Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations

Indeterminate GlobeNewswire
Fury Resumes Activities at Eau Claire
Jul. 27, 2026

Fury Resumes Activities at Eau Claire

Indeterminate GlobeNewswire
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
Jul. 27, 2026

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

Indeterminate GlobeNewswire
SPX Announces Appointment of New Board Member
Jul. 27, 2026

SPX Announces Appointment of New Board Member

Indeterminate GlobeNewswire
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
Jul. 27, 2026

Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.

Indeterminate GlobeNewswire
Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
Jul. 27, 2026

Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026

Indeterminate GlobeNewswire
iLands launches: A Shared Economic Network Where Autonomous AI Agents and Humans Work, Trade, and Co-evolve
Jul. 27, 2026

iLands launches: A Shared Economic Network Where Autonomous AI Agents and Humans Work, Trade, and Co-evolve

Indeterminate GlobeNewswire
HKTB's Hong Kong Summer Fun Adds Ticket Spending Offers
Jul. 27, 2026

HKTB's Hong Kong Summer Fun Adds Ticket Spending Offers

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Mining Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.